Abstract
Introduction
Carboplatin dosing based on renal function and therapeutic monitoring have been previously shown to be beneficial in the treatment of children with cancer. However, the applicability of such approaches to the treatment of premature or newborn infants, where kidney function may change markedly with advancing gestational and postnatal age, is unknown. Diagnosis of retinoblastoma in a preterm infant provided a rare opportunity to carry out adaptive carboplatin dosing in a patient with immature renal function.
Case report
A preterm female infant born at a gestational age of 32 weeks was diagnosed with bilateral retinoblastoma at 35 weeks. Carboplatin treatment with real-time pharmacokinetic monitoring was initiated on day 26 of life at an initial dose of 6.6 mg/kg. Plasma samples were obtained at specified time points and carboplatin levels quantified by atomic absorption spectrometry. Additional doses of carboplatin were determined by pharmacokinetic monitoring based on the achievement of carboplatin AUC values of 5.2–7.8 mg/ml min on three courses of treatment. Increased carboplatin doses administered on successive courses of treatment reflected a greater than twofold increase in drug clearance, from 3.4–7.1 ml/min over a 7-week period. Pharmacokinetically-guided carboplatin dosing led to the attainment of AUCs within 10% of target values on each course of treatment. The patient completed five courses of carboplatin with both tumours defined as inactive after this treatment period.
Conclusions
Data obtained from studying this patient suggests that adaptive carboplatin monitoring represents a feasible and beneficial clinical approach in preterm infants or neonates.
References
Thomas HD, Boddy AV, English MW, Hobson R, Imeson J, Lewis I, Morland B, Pearson ADJ, Pinkerton R, Price L, Stevens M, Newell DR (2000) Prospective validation of renal function-based carboplatin dosing in children with cancer: a United Kingdom Children’s Cancer Study Group trial. J Clin Oncol 18:3614–3621
Jodrell DI, Egorin MJ, Canetta RM, Langenberg P, Goldbloom EP, Burroughs JN, Goodlow JL, Tan S, Wiltshaw E (1992) Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer. J Clin Oncol 10:520–528
Newell DR, Siddik ZH, Gumbrell LA, Boxall FE, Gore ME, Smith IE, Calvert AH (1987) Plasma free platinum pharmacokinetics in patients treated with high dose carboplatin. Eur J Cancer Clin Oncol 23:1399–1405
Veal GJ, English MW, Grundy RG, Shakespeare C, Glaser A, Waters F, Holden V, O’Meara A, Michalski A, Howe K, Cole S, Boddy AV (2004) Pharmacokinetically guided dosing of carboplatin in paediatric cancer patientswith bilateral nephrectomy. Cancer Chemother Pharmacol 54:295–300
Veal GJ, Errington J, Tilby MJ, Pearson ADJ, Foot ABM, McDowell H, Ellershaw C, Pizer B, Nowell GM, Pearson DG, Boddy AV, UKCCSG Pharmacology Working Group (2007) Adaptive dosing and platinum-DNA adduct formation in children receiving high dose carboplatin for the treatment of solid tumours. Br J Cancer 96:725–731
Van der Heijden AJ, Grose WFA, Ambagtsheer JJ, Provoost AP, Wolff ED, Sauer PJJ (1988) Glomerular filtration rate in the preterm infant: the relation to gestational and postnatal age. Eur J Paediatr 148:24–28
Veal GJ, Dias C, Price L, Parry A, Errington J, Hale J, Pearson ADJ, Boddy AV, Newell DR, Tilby MJ (2001) Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy. Clin Cancer Res 7:2205–2212
Peng B, Boddy AV, Cole M, Pearson AD, Chatelut E, Rubie H, Newell DR (1995) Comparison of methods for the estimation of carboplatin pharmacokinetics in paediatric cancer patients. Eur J Cancer 31A:1804–1810
Van den Anker JN (1996) Pharmacokinetics and renal function in preterm infants. Acta Paediatr 85:1393–1399
Miall LS, Henderson MJ, Turner AJ, Brownlee KG, Brocklebank T, Newell SJ, Allgar VL (1999) Plasma creatinine rises dramatically in the first 48 hours of life in preterm infants. Pediatrics 104:76
Chevalier R (1996) Developmental renal physiology of the low birth weight pre-term newborn. J Urol 156:714–719
Wilkins BH (1992) Renal function in sick very low birthweight infants: 1 glomerular filtration rate. Arch Dis Child 67:1140–1145
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Picton, S.V., Keeble, J., Holden, V. et al. Therapeutic monitoring of carboplatin dosing in a premature infant with retinoblastoma. Cancer Chemother Pharmacol 63, 749–752 (2009). https://doi.org/10.1007/s00280-008-0787-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00280-008-0787-6